Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAZEMETOSTAT HYDROBROMIDE for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where TAZEMETOSTAT HYDROBROMIDE was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for TAZEMETOSTAT HYDROBROMIDE

Side Effect Reports % Deaths Hosp.
Off label use 298 22.5% 60 48
Fatigue 292 22.1% 10 41
Disease progression 267 20.2% 44 44
Nausea 207 15.7% 12 31
Product dose omission issue 183 13.8% 4 32
Death 106 8.0% 105 27
Diarrhoea 100 7.6% 2 11
Decreased appetite 81 6.1% 4 17
Asthenia 75 5.7% 5 29
Vomiting 75 5.7% 8 16
Constipation 66 5.0% 2 5
Covid-19 65 4.9% 4 30
Alopecia 61 4.6% 2 8
Headache 61 4.6% 3 5
Pain 58 4.4% 5 17

Other Indications for TAZEMETOSTAT HYDROBROMIDE

Follicular lymphoma (439) Soft tissue sarcoma (298) Off label use (102) B-cell lymphoma (91) Malignant connective tissue neoplasm (72) Product used for unknown indication (54) Epithelioid sarcoma (46) Follicular lymphoma stage ii (38) Follicular lymphoma stage i (34) Brain neoplasm malignant (31)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

TAZEMETOSTAT HYDROBROMIDE Full Profile All Diffuse large b-cell lymphoma Drugs TAZEMETOSTAT HYDROBROMIDE Demographics TAZEMETOSTAT HYDROBROMIDE Timeline